The estimated Net Worth of John M. Dineen is at least $454 Tysiąc dollars as of 13 November 2023. Mr. Dineen owns over 1,827 units of Syneos Health Inc stock worth over $78,524 and over the last 9 years he sold SYNH stock worth over $0. In addition, he makes $375,000 as Independent Chairman of the Board at Syneos Health Inc.
Sign up
Mr. Dineen SYNH stock SEC Form 4 insiders trading
John has made over 3 trades of the Syneos Health Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 1,827 units of SYNH stock worth $108,743 on 13 November 2023.
The largest trade he's ever made was buying 100,000 units of Syneos Health Inc stock on 12 August 2015 worth over $1,015,000. On average, John trades about 3,454 units every 94 days since 2015. As of 13 November 2023 he still owns at least 1,827 units of Syneos Health Inc stock.
You can see the complete history of Mr. Dineen stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Dineen biography
John M. Dineen serves as Independent Chairman of the Board of the Company. He was appointed as the independent Chairman of the Board of Syneos Health in December 2018. Mr. Dineen brings to the role more than 30 years of healthcare, technology and international management experience, most recently serving as Chief Executive Officer of GE’s Healthcare business from 2008 to 2014. Previously, Mr. Dineen spent more than two decades in a variety of other global leadership positions within GE, including President and Chief Executive Officer of GE Transportation, President of GE Plastics, General Manager of GE’s Power Equipment business, and General Manager of GE’s Appliances, Microwave and Air-Conditioning businesses. Since 2015, Mr. Dineen has served as an operating advisor of the investment firm Clayton, Dubilier & Rice LLC. He also currently serves on the board of directors of Cognizant Technology Solutions Corporation (Nasdaq:CTSH), a leading provider of information technology, consulting, and business process services, where he serves on the Finance and Strategy Committee and Nominating, Governance and Public Affairs Committee. He also currently serves as the chairman of the board of directors of Healogics and Carestream Dental. Mr. Dineen received Bachelor’s degrees in Biology and Computer Science from the University of Vermont where he now serves on the board of trustees.
What is the salary of John Dineen?
As the Independent Chairman of the Board of Syneos Health Inc, the total compensation of John Dineen at Syneos Health Inc is $375,000. There are 10 executives at Syneos Health Inc getting paid more, with Alistair Macdonald having the highest compensation of $7,646,360.
How old is John Dineen?
John Dineen is 57, he's been the Independent Chairman of the Board of Syneos Health Inc since 2018. There are 4 older and 17 younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.
Insiders trading at Syneos Health Inc
Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado oraz Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.
What does Syneos Health Inc do?
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
What does Syneos Health Inc's logo look like?
Complete history of Mr. Dineen stock trades at Cognizant Technology Solutions, Lam Research, Merrimack Pharmaceuticals Inc oraz Syneos Health Inc
Syneos Health Inc executives and stock owners
Syneos Health Inc executives and other stock owners filed with the SEC include:
-
Alistair Macdonald,
Chief Executive Officer, Director -
Jason Meggs,
Chief Financial Officer -
Paul Colvin,
President - Clinical Solutions -
Michelle Keefe,
President - Commercial Solutions -
Jonathan Olefson,
General Counsel, Corporate Secretary -
Alistair Macdonald,
CEO & Director -
Jason M. Meggs,
Chief Financial Officer -
Paul D. Colvin,
Chief Bus. Officer -
Michelle Keefe,
Pres of Commercial Solutions -
Jonathan Olefson,
Gen. Counsel & Corp. Sec. -
John Dineen,
Independent Chairman of the Board -
William Klitgaard,
Independent Director -
Kenneth Meyers,
Independent Director -
Linda Harty,
Independent Director -
Matthew Monaghan,
Independent Director -
Joshua Nelson,
Independent Director -
Todd Abbrecht,
Independent Director -
Bernadette Connaughton,
Independent Director -
Thomas Allen,
Independent Director -
John Maldonado,
Independent Director -
Ronnie Speight,
Senior Vice President, Investor Relations -
Robert Parks,
Executive Vice President, Chief Accounting Officer -
Lisa van Capelle,
Chief Human Resource Officer -
Dr. Judith Ng-Cashin M.D.,
Chief Scientific Officer -
Kristen Spensieri,
Global Head of Corp. Communications & Marketing -
Larry A. Pickett Jr.,
Chief Information & Digital Officer -
Dr. Judith Ng-Cashin,
Chief Scientific Officer -
Donna Hildebrand Kralowetz,
Sr. VP of Fin. & Principal Accounting Officer -
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Ma Doubl...,
-
Tom Allen,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Christopher L Gaenzle,
CAO, GC & Sec -
Michael Adam Bell,
Director -
Joshua M Nelson,
-
Todd M Abbrecht,
-
H. Lee Advisors, Llcthl Hol...,
-
H. Lee Advisors, Llc Thomas...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llc Thomas...,
-
H. Lee Advisors, Llcthl Fun...,
-
H. Lee Equity Fund Vi, L.P....,
-
Christian Tucat,
Chief Business Officer -
Michael Lee Brooks,
Chief Operating Officer -
Barbara W. Bodem,
Director -
Alfonso G Zulueta,
Director -
Stanford Rudnick,
See remarks -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Michael J. Bonello,
Chief Financial Officer -
Donna Hildebrand Kralowetz,
EVP, Chief Accounting Officer -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Maap Gpe...,
-
David S. Wilkes,
Director